The total return over the past 12 months is -17.41% vs. +16.94% for the S&P 500. So far it's up +51.12% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (17.41%) | (16.57%) | (35.70%) | (43.80%) | N/A | N/A |
| Total Return CAGR | (17.41%) | (16.57%) | (35.70%) | (43.80%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Immunic, Inc. (IMUX)
| Year | Start price | End price | IMUX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.34 | $8.07 | +51.12% | +14.51% | +36.61% |
| 2025 | $10.00 | $5.34 | (46.60%) | +17.72% | (64.32%) |
| 2024 | $15.00 | $10.00 | (33.33%) | +24.89% | (58.22%) |
| 2023 | $14.00 | $15.00 | +7.14% | +26.19% | (19.05%) |
| 2022 | $95.70 | $14.00 | (85.37%) | (18.17%) | (67.20%) |
| 2021 | $152.90 | $95.70 | (37.41%) | +28.74% | (66.15%) |
| 2020 | $97.00 | $152.90 | +57.63% | +18.37% | +39.26% |
| 2019 | $74.40 | $97.00 | +30.38% | +31.22% | (0.84%) |
| 2018 | $2,380.00 | $74.40 | (96.87%) | (4.56%) | (92.31%) |
| 2017 | $1,740.00 | $2,380.00 | +36.78% | +21.70% | +15.08% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
